WOCKHARDT BIO AG FDA Approval ANDA 071918

ANDA 071918

WOCKHARDT BIO AG

FDA Drug Application

Application #071918

Application Sponsors

ANDA 071918WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001CONCENTRATE;ORALEQ 10MG BASE/ML0DOXEPIN HYDROCHLORIDEDOXEPIN HYDROCHLORIDE

FDA Submissions

ORIG1AP1988-07-20
LABELING; LabelingSUPPL2AP1991-04-02
LABELING; LabelingSUPPL3AP1992-02-12
LABELING; LabelingSUPPL4AP1993-11-24
LABELING; LabelingSUPPL5AP1995-08-17
LABELING; LabelingSUPPL6AP1995-08-17
LABELING; LabelingSUPPL7AP2001-01-11
LABELING; LabelingSUPPL8AP2001-11-05
LABELING; LabelingSUPPL10AP2007-06-26
LABELING; LabelingSUPPL12AP2008-08-13
LABELING; LabelingSUPPL14AP2014-07-17STANDARD

Submissions Property Types

SUPPL14Null7

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 71918
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.